Literature DB >> 19914106

The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection.

Matthew D Katz1, Maria F Serrano, Peter A Humphrey, Robert L Grubb, Ted A Skolarus, Feng Gao, Adam S Kibel.   

Abstract

OBJECTIVES: Lymphovascular invasion (LVI) correlates with adverse outcomes in numerous malignancies. However, its role in predicting outcomes in RCC is unclear. Herein, we evaluated what effect LVI had on metastasis free survival (MFS), disease-specific survival (DSS), and overall survival (OS) in patients with RCC treated with surgical excision.
METHODS: Eight hundred forty-one consecutive patients who underwent partial or radical nephrectomy from 1989 to 2004 were identified. Pathologic and gross features examined were LVI, subtype, Fuhrman grade, stage, and size. Age and gender were also analyzed. Slides were re-reviewed by a single pathologist (MS). Variables with P < 0.1 on univariate analysis were incorporated in a Cox proportional hazards multivariate model. MFS, DSS, and OS were described for patients with and without LVI using the Kaplan-Meier method, and compared with the log-rank test.
RESULTS: LVI was seen on H and E stained slides in 91 patients (11%); 120 (14%) developed metastatic disease, 91 (11%) died of RCC, and 306 (36%) died during a median follow-up of 61 months. While on univariate analysis, LVI was strongly associated with decreased MFS, DSS, and OS (P < 0.0001), on multivariate analysis, LVI was no longer statistically significant for MFS, DSS, and OS with a HR of 0.976 (95% CI: 0.583-1.63; P = 0.93), 0.96 (95% CI: 0.542-1.69; P = 0.88), and 1.24 (95% CI: 0.869-1.77; P = 0.24).
CONCLUSIONS: We found LVI to be associated with worse MFS, DSS, and OS on univariate analysis, but not on multivariate analysis for patients with nonmetastatic RCC. In contrast to previously reported studies, LVI may not be an independent prognostic variable in patients with localized RCC.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19914106     DOI: 10.1016/j.urolonc.2009.07.034

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  13 in total

Review 1.  Evaluation and management of small renal masses: looking beyond the tumor margin.

Authors:  Michael Garcia-Roig; Michael A Gorin; Merce Jorda
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

2.  Prognostic indicators of pulmonary metastasis in patients with renal cell carcinoma who have undergone radical nephrectomy.

Authors:  Ja Yoon Ku; Suk Kim; Seung Baek Hong; Jong Geun Lee; Chan Ho Lee; Seock Hwan Choi; Hong Koo Ha
Journal:  Oncol Lett       Date:  2019-01-09       Impact factor: 2.967

3.  Microvascular invasion as a prognostic indicator in renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Hai Huang; Xiu-Wu Pan; Yi Huang; Dan-Feng Xu; Xin-Gang Cui; Lin Li; Yi Hong; Lu Chen; Yi Gao; Lei Yin
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Impact of preoperative radiological and postoperative pathological findings on survival of patients after radical nephrectomy performed with the indication of renal cell carcinoma.

Authors:  Abdulmuttalip Şimşek; Onur Küçüktopcu; Fatih Akbulut; Faruk Özgör; Elif Küçüktopcu; Metin Savun; Yalçın Berberoğlu; Gökhan Gürbüz
Journal:  Turk J Urol       Date:  2015-03

5.  Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma.

Authors:  Manuel S Eisenberg; John C Cheville; R Houston Thompson; Dharam Kaushik; Christine M Lohse; Stephen A Boorjian; Brian A Costello; Bradley C Leibovich
Journal:  J Urol       Date:  2013-01-23       Impact factor: 7.450

6.  Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.

Authors:  Zhen Chen; Yingjie Shao; Min Fan; Qianfeng Zhuang; Kun Wang; Wei Cao; Xianlin Xu; Xiaozhou He
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 7.  Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.

Authors:  Hui-Ming Jiang; Jin-Huan Wei; Zhi-Ling Zhang; Yong Fang; Bang-Fen Zhou; Zhen-Hua Chen; Jun Lu; Bing Liao; Fang-Jian Zhou; Jun-Hang Luo; Wei Chen
Journal:  Int Urol Nephrol       Date:  2015-11-20       Impact factor: 2.370

8.  Possible role of sonic hedgehog and epithelial-mesenchymal transition in renal cell cancer progression.

Authors:  Hosny M Behnsawy; Katsumi Shigemura; Fatma Y Meligy; Fukashi Yamamichi; Masuo Yamashita; Wen-Chin Haung; Xiangyan Li; Hideaki Miyake; Kazushi Tanaka; Masato Kawabata; Toshiro Shirakawa; Masato Fujisawa
Journal:  Korean J Urol       Date:  2013-08-07

9.  Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma.

Authors:  U-Syn Ha; Kyu Won Lee; Jin-Hyung Jung; Seok-Soo Byun; Cheol Kwak; Jinsoo Chung; Eu Chang Hwang; Yong-June Kim; Tae Gyun Kwon; Seok Ho Kang; Sung-Hoo Hong
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

10.  Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients.

Authors:  Zhen Chen; Yingjie Shao; Hongwei Yao; Qianfeng Zhuang; Kun Wang; Zhaoyu Xing; Xianlin Xu; Xiaozhou He; Renfang Xu
Journal:  Oncotarget       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.